Therapeutic Targeting of Cancer

Therapeutic targeting of cancer involves designing and applying treatments that specifically target cancer cells and the mechanisms driving their growth, survival, and spread, while minimizing harm to normal cells. This approach includes a range of strategies, from targeted therapies and immunotherapies to novel drug delivery systems and combination therapies. It involves a multifaceted approach that leverages advancements in molecular biology, immunology, and nanotechnology. Continued research and innovation are crucial for improving the efficacy, safety, and accessibility of cancer treatments, ultimately aiming to provide personalized and effective care for cancer patients.

  • Gene Therapy
  • Chemo-Immunotherapy
  • Hormonal Therapy
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Monoclonal Antibodies

 

      Related Conference of Therapeutic Targeting of Cancer

      April 28-29, 2025

      35th Experts Meet On Cancer Research & Therapy

      Paris, France
      May 26-27, 2025

      15th World Congress on Breast Cancer

      Rome, Italy
      June 16-17, 2025

      26th World Congress on Cancer Summit

      Amsterdam, Netherlands
      July 14-15, 2025

      5th World Congress on Breast Cancer

      Berlin, Germany
      July 28-29, 2025

      45th Euro Congress on Cancer Science & Therapy

      Paris, France
      August 18-19, 2025

      6th Cancer Diagnostics & Treatment Conference

      Rome, Italy
      October 13-14, 2025

      8th International Conference on Anti-Cancer Drugs & Therapies

      Aix-en-Provence, France
      October 20-21, 2025

      21st International Conference on Cancer Research

      Barcelona, Spain
      November 24-25, 2025

      43rd World Cancer Conference

      Barcelona, Spain

      Therapeutic Targeting of Cancer Conference Speakers

        Recommended Sessions

        Related Journals

        Are you interested in